Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.

Su-Ni Tang | Junsheng Fu | Sharmila Shankar | Rakesh K Srivastava
PloS one | 2012

Signal Transducer and Activator of Transcription 3 (STAT3) is an oncogene, which promotes cell survival, proliferation, motility and progression in cancer cells. Targeting STAT3 signaling may lead to the development of novel therapeutic approaches for human cancers. Here, we examined the effects of epigallocathechin gallate (EGCG) on STAT3 signaling in pancreatic cancer cells, and assessed the therapeutic potential of EGCG with gemcitabine or JAK3 inhibitor CP690550 (Tasocitinib) for the treatment and/or prevention of pancreatic cancer.

Pubmed ID: 22348037

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA114469
  • Agency: NCI NIH HHS, United States
    Id: R01CA114469
  • Agency: NCI NIH HHS, United States
    Id: R01CA125262
  • Agency: NCI NIH HHS, United States
    Id: R01CA125262-02S1
  • Agency: NCI NIH HHS, United States
    Id: R01 CA125262

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PANC-1 (tool)

RRID:CVCL_0480

Cell line PANC-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

AsPC-1 (tool)

RRID:CVCL_0152

Cell line AsPC-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions